Pfizer-KineMed Collaboration Extends to Target Novel Diabetes Pathways

News   Mar 28, 2013

 
Pfizer-KineMed Collaboration Extends to Target Novel Diabetes Pathways
 
 
 

RELATED ARTICLES

Barrier to Liquid Biopsies Overcome with Blood Stabilization Technique

News

A new technique that prolongs the lifespan of blood samples could be a breakthrough for liquid biopsy assays.

READ MORE

Artificial Enzyme Can Catalyze Reactions

News

Artificial Biology has taken a step forward as a study shows the catalytic ability of a synthetic enzyme.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE